Showing results (261-270 of 345) with videos related to
Sort By:
Pageof 35
The Journal of Infectious Diseases|February 4, 2011
Concordance of CCR5 genotypes that influence cell-mediated immunity and HIV-1 disease progression ratesGabriel Catano, Zoya A Chykarenko, Andrea Mangano, et al.Plos One|June 5, 2013
Elucidating the aetiology of human Campylobacter coli infectionsFrancois Roux, Emma Sproston, Ovidiu Rotariu, et al.International Journal of Oncology|May 6, 2021
Reduced kinase D‑interacting substrate of 220 kDa (Kidins220) in pancreatic cancer promotes EGFR/ERK signalling and disease progressionShuo Cai, Zhiwei Sun, Ping-Hui Sun, et al.Bioorganic & Medicinal Chemistry Letters|March 26, 2009
Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitorsJoanne L Thomson, Wesley P Blackaby, Andrew S R Jennings, et al.Journal of Pharmaceutical Sciences|August 8, 2020
Simultaneous Monitoring and Comparison of Multiple Product Quality Attributes for Cell Culture Processes at Different Scales Using a LC/MS/MS Based Multi-Attribute MethodYang Liu, Janice Fernandez, Zheng Pu, et al.Transfusion|June 2, 2020
From battlefront to homefront: creation of a civilian walking blood bankMaxwell A Braverman, Alison Smith, Charles Patrick Shahan, et al.Mabs|June 15, 2017
A high-throughput platform for population reformatting and mammalian expression of phage display libraries to enable functional screening as full-length IgGXiaodong Xiao, Julie A Douthwaite, Yan Chen, et al.BMC Research Notes|October 10, 2014
Lessons in participant retention in the course of a randomized controlled clinical trialOlubukola T Idoko, Olumuyiwa A Owolabi, Aderonke A Odutola, et al.The Journal of Infectious Diseases|February 7, 2019
A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?Janni Leung, Amy Peacock, Samantha Colledge, et al.Pediatric Blood & Cancer|July 21, 2016
Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemiaWeili Sun, Etan Orgel, Jemily Malvar, et al.Pageof 35